180 related articles for article (PubMed ID: 34473867)
1. Eugenol modulates genomic methylation and inactivates breast cancer-associated fibroblasts through E2F1-dependent downregulation of DNMT1/DNMT3A.
Al-Kharashi LA; Bakheet T; AlHarbi WA; Al-Moghrabi N; Aboussekhra A
Mol Carcinog; 2021 Nov; 60(11):784-795. PubMed ID: 34473867
[TBL] [Abstract][Full Text] [Related]
2. Eugenol triggers apoptosis in breast cancer cells through E2F1/survivin down-regulation.
Al-Sharif I; Remmal A; Aboussekhra A
BMC Cancer; 2013 Dec; 13():600. PubMed ID: 24330704
[TBL] [Abstract][Full Text] [Related]
3. Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models.
Buocikova V; Longhin EM; Pilalis E; Mastrokalou C; Miklikova S; Cihova M; Poturnayova A; Mackova K; Babelova A; Trnkova L; El Yamani N; Zheng C; Rios-Mondragon I; Labudova M; Csaderova L; Kuracinova KM; Makovicky P; Kucerova L; Matuskova M; Cimpan MR; Dusinska M; Babal P; Chatziioannou A; Gabelova A; Rundén-Pran E; Smolkova B
Biomed Pharmacother; 2022 Mar; 147():112662. PubMed ID: 35091237
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of DNMT1 and ERRα crosstalk suppresses breast cancer via derepression of IRF4.
Vernier M; McGuirk S; Dufour CR; Wan L; Audet-Walsh E; St-Pierre J; Giguère V
Oncogene; 2020 Oct; 39(41):6406-6420. PubMed ID: 32855526
[TBL] [Abstract][Full Text] [Related]
5. Tocilizumab suppresses the pro-carcinogenic effects of breast cancer-associated fibroblasts through inhibition of the STAT3/AUF1 pathway.
Al-Jomah N; Al-Mohanna FH; Aboussekhra A
Carcinogenesis; 2021 Dec; 42(12):1439-1448. PubMed ID: 34718441
[TBL] [Abstract][Full Text] [Related]
6. Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agent.
Lin HY; Kuo YC; Weng YI; Lai IL; Huang TH; Lin SP; Niu DM; Chen CS
Prostate; 2012 Dec; 72(16):1767-78. PubMed ID: 22539223
[TBL] [Abstract][Full Text] [Related]
7. Altered DNA methylation is associated with docetaxel resistance in human breast cancer cells.
Kastl L; Brown I; Schofield AC
Int J Oncol; 2010 May; 36(5):1235-41. PubMed ID: 20372798
[TBL] [Abstract][Full Text] [Related]
8. Cucurbitacin I (JSI-124)-dependent inhibition of STAT3 permanently suppresses the pro-carcinogenic effects of active breast cancer-associated fibroblasts.
Al-Harbi B; Aboussekhra A
Mol Carcinog; 2021 Apr; 60(4):242-251. PubMed ID: 33621387
[TBL] [Abstract][Full Text] [Related]
9. Regulation of DNA methyltransferase 1 transcription in BRCA1-mutated breast cancer: a novel crosstalk between E2F1 motif hypermethylation and loss of histone H3 lysine 9 acetylation.
Li D; Bi FF; Cao JM; Cao C; Liu B; Yang Q
Mol Cancer; 2014 Feb; 13():26. PubMed ID: 24502362
[TBL] [Abstract][Full Text] [Related]
10. Reactivation of the tumour suppressor RASSF1A in breast cancer by simultaneous targeting of DNA and E2F1 methylation.
Montenegro MF; Sáez-Ayala M; Piñero-Madrona A; Cabezas-Herrera J; Rodríguez-López JN
PLoS One; 2012; 7(12):e52231. PubMed ID: 23251702
[TBL] [Abstract][Full Text] [Related]
11. KLF4, DAPK1 and SPG20 promoter methylation is not affected by DNMT1 silencing and hypomethylating drugs in lymphoma cells.
Frazzi R; Cusenza VY; Pistoni M; Canovi L; Cascione L; Bertoni F; Merli F
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34751409
[TBL] [Abstract][Full Text] [Related]
12. The DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2'-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer Cells.
Yan F; Shen N; Pang J; Molina JR; Yang P; Liu S
J Biol Chem; 2015 Jul; 290(30):18480-94. PubMed ID: 26085088
[TBL] [Abstract][Full Text] [Related]
13. Decorin (DCN) Downregulation Activates Breast Stromal Fibroblasts and Promotes Their Pro-Carcinogenic Effects through the IL-6/STAT3/AUF1 Signaling.
Aljagthmi WA; Alasmari MA; Daghestani MH; Al-Kharashi LA; Al-Mohanna FH; Aboussekhra A
Cells; 2024 Apr; 13(8):. PubMed ID: 38667295
[TBL] [Abstract][Full Text] [Related]
14. Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest.
Vijayaraghavalu S; Dermawan JK; Cheriyath V; Labhasetwar V
Mol Pharm; 2013 Jan; 10(1):337-52. PubMed ID: 23215027
[TBL] [Abstract][Full Text] [Related]
15. Cromolyn chitosan nanoparticles reverse the DNA methylation of RASSF1A and p16 genes and mitigate DNMT1 and METTL3 expression in breast cancer cell line and tumor xenograft model in mice.
Motawi TK; El-Maraghy SA; Sabry D; Nady OM; Senousy MA
Chem Biol Interact; 2022 Sep; 365():110094. PubMed ID: 35961540
[TBL] [Abstract][Full Text] [Related]
16. Temporal DNA methylation pattern and targeted therapy in colitis-associated cancer.
Li J; Su X; Dai L; Chen N; Fang C; Dong Z; Fu J; Yu Y; Wang W; Zhang H; Wang H; Ji Y; Liu Y; Cheng L; Shi G; Zhang S; Yang Y; Deng H
Carcinogenesis; 2020 Apr; 41(2):235-244. PubMed ID: 31802101
[TBL] [Abstract][Full Text] [Related]
17. Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts.
Moatassim-Billah S; Duluc C; Samain R; Jean C; Perraud A; Decaup E; Cassant-Sourdy S; Bakri Y; Selves J; Schmid H; Martineau Y; Mathonnet M; Pyronnet S; Bousquet C
Oncotarget; 2016 Jul; 7(27):41584-41598. PubMed ID: 27177087
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of Dnmt1 and Dnmt3a gene expression disrupts preimplantation embryo development through global DNA methylation.
Uysal F; Cinar O; Can A
J Assist Reprod Genet; 2021 Dec; 38(12):3135-3144. PubMed ID: 34533678
[TBL] [Abstract][Full Text] [Related]
19. High DNMT1 Expression in Stromal Fibroblasts Promotes Angiogenesis and Unfavorable Outcome in Locally Advanced Breast Cancer Patients.
Al-Kharashi LA; Tulbah A; Arafah M; Eldali AM; Al-Tweigeri T; Aboussekhra A
Front Oncol; 2022; 12():877219. PubMed ID: 35719957
[TBL] [Abstract][Full Text] [Related]
20. The frequency of CpG and non-CpG methylation of Notch3 gene promoter determines its expression levels in breast cancer cells.
Xiao W; Liu X; Niu X; Li C; Guo Y; Tan J; Xiong W; Fan L; Li Y
Exp Cell Res; 2020 Jan; 386(2):111743. PubMed ID: 31770532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
